In Brief: NeoPath
This article was originally published in The Gray Sheet
Executive Summary
NeoPath: Redmond, Washington-based company issues retraction Feb. 9 for statements made in a Sept. 6, 1995 release comparing NeoPath's AutoPap 300QC automated cervical cytology reader with Neuromedical Systems, Inc.'s Papnet system ("The Gray Sheet" Oct. 9, 1995, p. 6). "FDA has determined" that a comparison of the two systems' "relative sensitivity" made in the Sept. 6 release "represents an unfair comparison of these two medical devices," NeoPath says, adding that the company "did not intend to suggest that a direct comparison between" AutoPap and Papnet "had been attempted"...